4//SEC Filing
SOLTA MEDICAL INC 4
Accession 0001181431-14-004063
CIK 0001171298operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 8:28 PM ET
Size
7.1 KB
Accession
0001181431-14-004063
Insider Transaction Report
Form 4
Parr Lisa D
VP,Regulatory/Clinical Affairs
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$0.15/sh−100,000$15,000→ 0 totalExercise: $2.77Exp: 2022-12-11→ Common Stock (100,000 underlying) - Disposition to Issuer
Common Stock
2014-01-23$2.92/sh−3,524$10,290→ 0 total
Footnotes (2)
- [F1]Disposed of pursuant to the merger of the Issuer with Valeant Pharmaceuticals International, a Delaware corporation (the "Merger"), at the merger consideration of $2.92 per share (the "Merger Consideration").
- [F2]This option, which had become fully vested and exercisable, was cancelled at the closing of the Merger in exchange for a cash payment equal to the product of (a) the number of shares underlying this option and (b) the difference between the Merger Consideration and the exercise price per share of this option.
Documents
Issuer
SOLTA MEDICAL INC
CIK 0001171298
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001171298
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 8:28 PM ET
- Size
- 7.1 KB